Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference

Rhea-AI Summary

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced its participation in the 11th Annual Leerink Global Healthcare Conference, scheduled from February 14-18, 2022. The company's corporate presentation will take place virtually on February 16, 2022, at 8 am ET. Interested participants can listen to the presentation by registering through a public link or by visiting the Investor section of Aurinia's corporate website. Aurinia is focused on developing therapies for serious diseases with high unmet medical needs, notably introducing the first FDA-approved oral therapy for active lupus nephritis in January 2021.

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that the company will deliver a corporate presentation at the 11^th Annual Leerink Global Healthcare Conference (February 14-18, 2022). The presentation will take place virtually on Wednesday, February 16, 2022 at 8 am ET. Interested parties can register to listen to the presentation via the public link here or access via the Investor section of the Aurinia corporate website - www.auriniapharma.com, under "News/Events.”

ABOUT AURINIA

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021, the Company introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220203005261/en/

Investor and Corporate Contact:

Dana Lynch, IR & Corporate Communications

dlynch@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When is Aurinia Pharmaceuticals' presentation at the Leerink Global Healthcare Conference?

Aurinia Pharmaceuticals will present on February 16, 2022, at 8 am ET.

How can I listen to Aurinia Pharmaceuticals' corporate presentation?

You can register to listen to the presentation through a public link or visit the Investor section of Aurinia's website.

What significant treatment did Aurinia Pharmaceuticals introduce in January 2021?

In January 2021, Aurinia introduced the first FDA-approved oral therapy for treating adult patients with active lupus nephritis.

Where is Aurinia Pharmaceuticals headquartered?

Aurinia Pharmaceuticals is headquartered in Victoria, British Columbia.

What is the stock symbol for Aurinia Pharmaceuticals?

The stock symbol for Aurinia Pharmaceuticals is AUPH.